<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01611181</url>
  </required_header>
  <id_info>
    <org_study_id>VN 2004/30</org_study_id>
    <nct_id>NCT01611181</nct_id>
  </id_info>
  <brief_title>Iron Substitution After Total Knee Arthroplasty</brief_title>
  <official_title>Iron Substitution After Total Knee Arthroplasty - a Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northern Orthopaedic Division, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aalborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northern Orthopaedic Division, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemoboost is a registered natural product containing specially processed haemolysed
      haemoglobin and iron dextran. It is marketed for human use on the basis of many years' use
      and documented effect in veterinary medicine. Iron dextran was introduced for use in human
      medicine in 1954.

      Krauterblut is a registered natural product made from a number of herbs where the active
      substance is ferrous gluconate. Both drugs have been available for a number of years and have
      become increasingly popular among patients and healthcare staff due to a reduction in adverse
      effects.

      The objective of this study is to determine the effect and adverse effects of the natural
      products Hemoboost and Kräuterblut compared with the usually administered ferrous sulphate in
      knee arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hip and knee arthroplasties are performed with increasing frequency in the western world, and
      in Denmark approximately 12,000 operations are performed annually (2/1000/year). The
      perioperative and postoperative blood loss generally constitutes ½ -1½ litres which is
      frequently associated with symptom-producing anaemia which obstructs mobilisation and
      increases the risk of complications.

      Postoperative iron supplementation for a period of up to 12 weeks is therefore a frequently
      adopted practice. However, there is no consensus or evidence that support postoperative iron
      supplementation and the effects of iron deficiency are unclear. It is well-known that iron
      supplementation causes gastrointestinal adverse effects in up to 25% of cases.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Haemoglobin concentration</measure>
    <time_frame>3 months</time_frame>
    <description>Determine whether peroral iron substitution of Hemo-Boost or Krauterblut results in the same increase of haemoglobin concentration as the usually administered ferrous sulphate.
To study the adverse effects of the natural products Hemo-Boost and Krauterblut compared with ferrous sulphate in knee arthroplasty.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain measurement</measure>
    <time_frame>3 months</time_frame>
    <description>Pain scores on the Visual Analog Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption af analgesics</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing of ulcer</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic need for facilities</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of activity</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Haemodynamic Rebound</condition>
  <arm_group>
    <arm_group_label>Hemoboost (iron supplementation)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A registered natural product containing specially haemolysed haemoglobin and iron dextran.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kräuterblut (iron supplementation)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A registered natural product made from a number of herbs with ferrous gluconate as the active substance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ferrofumerat (iron supplementation)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ferrous sulphate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hemoboost</intervention_name>
    <description>200 mg specially processed haemoglobin and 30 mg iron dextran equivalent to 10.5 mg organically bound iron in 1 tablet twice daily.</description>
    <arm_group_label>Hemoboost (iron supplementation)</arm_group_label>
    <other_name>No other names.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Kräuterblut</intervention_name>
    <description>40 mg iron, 20 ml twice daily.</description>
    <arm_group_label>Kräuterblut (iron supplementation)</arm_group_label>
    <other_name>No other names.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferrofumerat</intervention_name>
    <description>200 mg ferrous sulphate as 1 tablet twice daily.</description>
    <arm_group_label>Ferrofumerat (iron supplementation)</arm_group_label>
    <other_name>No other names.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  ASA group I-II

        Exclusion Criteria:

          -  malignant disorder

          -  chronic renal insufficiency

          -  urinary tract infection

          -  haemorrhagic diathesis

          -  haemoglobin &lt; 7 mmol/l

          -  dementia or mental disorder incompatible with survey participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sten Rasmussen, M.D.Sci.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Division, North Denmark Region, Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Søren Lundbye-Christensen, Ph.d.</last_name>
    <role>Study Chair</role>
    <affiliation>Aalborg University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mogens B. Joergensen, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Orthopaedic Division, North Denmark Region, Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ole Simonsen, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Orthopaedic Division, North Denmark Region, Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Frederikshavn Hospital, Aalborg Hospital/Aarhus University</name>
      <address>
        <city>Frederikshavn</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2012</study_first_submitted>
  <study_first_submitted_qc>May 31, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2012</study_first_posted>
  <last_update_submitted>March 28, 2014</last_update_submitted>
  <last_update_submitted_qc>March 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Iron supplementation</keyword>
  <keyword>Iron deficiency</keyword>
  <keyword>Hip arthroplasty</keyword>
  <keyword>Knee arthroplasty</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

